Jorkasky Diane's Form 4 filing
Altimmune, Inc. (ALT) · filed Jun 28, 2022
- Accession no.
- 0001104659-22-075223
- Filed
- Jun 28, 2022
- Trade date
- Jun 27, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $206.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jorkasky DianeCIK 0001527204 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 27, 2022 | Common Stock, par value $0.0001 | MOption exerciseAcquired | +17,610 | $3.15 | +$55,471.5 | 17,610 | Direct | |
| Jun 27, 2022 | Common Stock, par value $0.0001 | SSaleDisposed | −17,610 | $11.75 | −$206,917.5 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 27, 2022 | Common Stock, par value $0.0001 | MOption exerciseDisposed | −40,000 | $0.00 | $0 | 22,390 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.